Table 5.
100-Point Allocation and First-Choice Treatment Mode Preferences by Country
| US (n=30) | France (n=10) | Germany (n=10) | Italy (n=10) | Spain (n=10) | Switzerland (n=10) | UK (n=10) | Brazil (n=10) | Total (n=100) | |
|---|---|---|---|---|---|---|---|---|---|
| 100-Point Allocation Points, mean (SD) | |||||||||
| Oral | 56.3 (27.6) | 43.5 (31.5) | 43.5 (29.3) | 40.0 (35.3) | 53.5 (32.7) | 30.4 (24.1) | 48.0 (40.5) | 45.0 (49.7) | 47.3 (33.1) |
| Self-injection | 29.9 (26.4) | 43.0 (29.8) | 33.5 (25.2) | 34.0 (29.1) | 20.5 (20.1) | 38.6 (23.9) | 38.0 (37.4) | 0.0 (0.0) | 29.7 (27.7) |
| Clinic-injection | 4.3 (6.5) | 3.5 (7.5) | 5.0 (5.8) | 8.0 (9.5) | 9.3 (9.4) | 18.5 (21.5) | 6.0 (10.7) | 12.0 (31.6) | 7.5 (14.1) |
| Infusion | 9.5 (14.1) | 9.5 (20.9) | 18.0 (20.8) | 18.0 (23.6) | 16.7 (27.4) | 12.5 (11.6) | 8.0 (19.3) | 43.0 (47.6) | 15.4 (24.6) |
| First Choice,a n (%) | |||||||||
| Oral | 22 (73.3) | 5 (50.0) | 6 (60.0) | 5 (50.0) | 5 (50.0) | 4 (40.0) | 5 (50.0) | 5 (50.0) | 57 (57.0) |
| Self-injection | 8 (26.7) | 3 (30.0) | 2 (20.0) | 3 (30.0) | 3 (30.0) | 6 (60.0) | 4 (40.0) | 0 (0.0) | 29 (29.0) |
| Clinic-injection | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (10.0) | 0 (0.0) | 1 (10.0) | 2 (2.0) |
| Infusion | 2 (6.7) | 2 (20.0) | 2 (20.0) | 2 (20.0) | 2 (20.0) | 0 (0.0) | 1 (10.0) | 5 (50.0) | 16 (16.0) |
Notes: aPercentages sum to >100 because four patients provided ties for their first-choice mode; these tied modes were counted twice in the percentages (oral and self-injection [n=3]; oral and infusion [n=1]).
Abbreviations: n, number of patients; UK, United Kingdom; US, United States.